A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...

Colonialist accusations, trust issues, and not caring what Open AI is producing - AI ethicist Stephanie Antonian raises some ...

The goal is audacious, developing AGI that can match and eventually exceed human performance, across wide range of tasks, ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

Investors are worried about Google's falling market share. The Google Search engine saw its revenue rise 10% in Q1. Alphabet ...

Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...

Logan Kilpatrick has become the public face of Google's AI offensive, and, intentionally or not, a one-man marketing machine.

Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...

Ex-OpenAI board member warns Meta must move fast enough or risk losing top AI hires like IITian Trapit Bansal to rivals ...

Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...